Skin Biopsy Market Synopsis:
Skin Biopsy Market Size Was Valued at USD 113.8 Million in 2023, and is Projected to Reach USD 193.9 Million by 2032, Growing at a CAGR of 6.1% From 2024-2032.
The skin biopsy system is one that entails the identification and assessment of skin associated ailments and disorders by taking biopsies on secrete matter from the skin. This market covers various dermatological diseases such as skin cancer, inflammation diseases and infections with diagnosis being critical for patient treatment. Skin biopsies are important in diagnosing the type and character of skin lesions and establishing a differential diagnosis between benign and malignant tumours as well as to design individual treatment protocols. On grounds of diagnostic technologies, global skin biopsy market is experiencing steady growth primarily due to the rising instances of skins disorders, enhanced awareness among the patients as well as the doctors. Furthermore, the growth of factors such as rising healthcare costs and advancement in minimally invasive biopsy procedures also fuelling the market growth.
The skin biopsy market is extending year after year, especially for skin diseases such as skin cancer, which is one of the most common types of cancer mankind nowadays. Larger public awareness regarding early detection and technical and scientific development needs for enhanced diagnosis are the two primary opportunities responsible for the market’s growth. Furthermore, global healthcare facilities enhancement, especially in growing markets, have improved the availability of dermatological care to the populace increasing demand to the market.
Moreover, rising demand for dermatological diagnostic procedures such as dermatoscopy, dermoscopy, and confocal microscopy and changing technology preference such as punch biopsy tools, minimally invasive techniques, and implement of automated systems are also shifting the market scenario. In dermatology too, the use of artificial intelligence in diagnosis and prognosis of ailments is also creating a promising chance to the market players. Also, the favourable government policies and growing synchronisation of research institutes with diagnostic labs are likely to enhance the market in the future.
Skin Biopsy Market Trend Analysis:
Growing Adoption of Minimally Invasive Procedures
- The skin biopsy market is observing a transition towards less invasive procedures to diagnose a suspected disease without causing much discomfort to the patient. Shave biopsies and punch biopsies are getting popular among dermatologists since they take less time and experience and the patients’ healing time is also less. Also, the use of digital pathology and teledermatology has made it easier and timely to diagnose and plan for patient management. This is set to redefine the market by expanding access to diagnostic services especially in the periphery where the health facilities are scarce.
Rising Demand for Skin Cancer Diagnosis
- The constant increase in recent skin cancer cases creates a high growth opportunity for skin biopsy market. Basal cell carcinoma as well as squamous cell carcinoma are among the most frequent forms of skin cancer. The disease symptoms are often manifested in skin changes, so skin biopsies that allow for early diagnosis are vital for those patients to get a high likelihood of recovery. In addition, new molecular diagnostic technology and the introduction of biomarkers for skin cancer which impact the overall efficiency of biopsies will remain new avenues for improved market growth. The market’s key stakeholders are also considering designing compact and easy-to-operate biopsy tools that could change diagnostic approaches and scope.
Skin Biopsy Market Segment Analysis:
Skin Biopsy Market Segmented on the basis of type, Indication and end user.
By Type, Shave Biopsy segment is expected to dominate the market during the forecast period
- Of all the biopsies, shave biopsies are expected to dominate the global market share in the forecast period because of ease, cost, and effectiveness of diagnosing primary skin lesion. Shave biopsies are popular among dermatologists since they need little apparatus and can be done in outpatient clinics. Also, these procedures provide high diagnostic sensitivity to diseases like basal cell carcinoma and actinic keratosis, thus being popular among doctors.
- Rising incidence rates for skin diseases and the rising use of shave biopsies in healthcare facilities are key segment drivers. Also, the continuous advancement made on biopsy blades and equipment that are used in performing biopsy procedures are projected to steadily improve procedure results, thus sustaining the supremacy of this segment in the global market.
By Indication, Skin cancer segment expected to held the largest share
- Skin cancer segment is expected to have a lion’s share of the skin biopsy market because of increased incidences of melanoma as well as non-melanoma skin cancer. Per the global cancer statistics briefing note, there has been a steady rise in skin cancer diagnosis across the world arguing the importance of early diagnoses through tests like biopsies.
- Thanks to improved biopsy methods, as well as to campaigns by organizations, such as the American Academy of Dermatology, skin biopsies have become widely used for cancer diagnosis. In addition, rising adoption of precision medicine and molecular diagnostic in skin cancer segment is presumed to drive the segment growth rate in the market.
Skin Biopsy Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America is anticipated to control the skin biopsy market due to its high standard of health care, its channelized dermatology services, and increasing skin cancer rates in 2023. The region contributed to around 35-40% of the global market share fueled by strong government endorsement and increased preference for the effective biopsy systems. The United States have invested most in dermatology both in research and diagnosing technologies, thus dominating the market most. Also, the availability of strategic market players and a favorable reimbursement structure also strengthen the region’s position.
Active Key Players in the Skin Biopsy Market:
- 3Derm Systems Inc. (United States)
- AccuTec Blades Inc. (United States)
- BD (Becton, Dickinson, and Company) (United States)
- bioMérieux SA (France)
- Boston Scientific Corporation (United States)
- Cardinal Health (United States)
- Carl Zeiss AG (Germany)
- DermTech Inc. (United States)
- Eurofins Scientific (Luxembourg)
- Hologic Inc. (United States)
- Leica Microsystems (Germany)
- Medtronic plc (Ireland)
- Quest Diagnostics (United States)
- Roche Diagnostics (Switzerland)
- Thermo Fisher Scientific (United States)
- Other Active Players
|
Skin Biopsy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 113.8 Million |
|
Forecast Period 2024-32 CAGR: |
6.1% |
Market Size in 2032: |
USD 193.9 Million |
|
Segments Covered: |
By Type |
|
|
|
By Indication |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Skin Biopsy Market by By Type (2018-2032)
4.1 Skin Biopsy Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Shave Biopsy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Punch Biopsy
4.5 Excisional Biopsy
Chapter 5: Skin Biopsy Market by By Indication (2018-2032)
5.1 Skin Biopsy Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Skin cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Actinic keratosis
5.5 Dermatitis
5.6 Others
Chapter 6: Skin Biopsy Market by By End User (2018-2032)
6.1 Skin Biopsy Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Hospital and Clinics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Diagnostic Laboratories
6.5 Other
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Skin Biopsy Market Share by Manufacturer (2024)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 3DERM SYSTEMS INC. (UNITED STATES)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ACCUTEC BLADES INC. (UNITED STATES)
7.4 BD (UNITED STATES)
7.5 BIOMÉRIEUX SA (FRANCE)
7.6 BOSTON SCIENTIFIC CORPORATION (UNITED STATES)
7.7 CARDINAL HEALTH (UNITED STATES)
7.8 CARL ZEISS AG (GERMANY)
7.9 DERMTECH INC. (UNITED STATES)
7.10 EUROFINS SCIENTIFIC (LUXEMBOURG)
7.11 HOLOGIC INC. (UNITED STATES)
7.12 LEICA MICROSYSTEMS (GERMANY)
7.13 MEDTRONIC PLC (IRELAND)
7.14 QUEST DIAGNOSTICS (UNITED STATES)
7.15 ROCHE DIAGNOSTICS (SWITZERLAND)
7.16 THERMO FISHER SCIENTIFIC (UNITED STATES)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Skin Biopsy Market By Region
8.1 Overview
8.2. North America Skin Biopsy Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By By Type
8.2.4.1 Shave Biopsy
8.2.4.2 Punch Biopsy
8.2.4.3 Excisional Biopsy
8.2.5 Historic and Forecasted Market Size By By Indication
8.2.5.1 Skin cancer
8.2.5.2 Actinic keratosis
8.2.5.3 Dermatitis
8.2.5.4 Others
8.2.6 Historic and Forecasted Market Size By By End User
8.2.6.1 Hospital and Clinics
8.2.6.2 Diagnostic Laboratories
8.2.6.3 Other
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Skin Biopsy Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By By Type
8.3.4.1 Shave Biopsy
8.3.4.2 Punch Biopsy
8.3.4.3 Excisional Biopsy
8.3.5 Historic and Forecasted Market Size By By Indication
8.3.5.1 Skin cancer
8.3.5.2 Actinic keratosis
8.3.5.3 Dermatitis
8.3.5.4 Others
8.3.6 Historic and Forecasted Market Size By By End User
8.3.6.1 Hospital and Clinics
8.3.6.2 Diagnostic Laboratories
8.3.6.3 Other
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Skin Biopsy Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By By Type
8.4.4.1 Shave Biopsy
8.4.4.2 Punch Biopsy
8.4.4.3 Excisional Biopsy
8.4.5 Historic and Forecasted Market Size By By Indication
8.4.5.1 Skin cancer
8.4.5.2 Actinic keratosis
8.4.5.3 Dermatitis
8.4.5.4 Others
8.4.6 Historic and Forecasted Market Size By By End User
8.4.6.1 Hospital and Clinics
8.4.6.2 Diagnostic Laboratories
8.4.6.3 Other
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Skin Biopsy Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By By Type
8.5.4.1 Shave Biopsy
8.5.4.2 Punch Biopsy
8.5.4.3 Excisional Biopsy
8.5.5 Historic and Forecasted Market Size By By Indication
8.5.5.1 Skin cancer
8.5.5.2 Actinic keratosis
8.5.5.3 Dermatitis
8.5.5.4 Others
8.5.6 Historic and Forecasted Market Size By By End User
8.5.6.1 Hospital and Clinics
8.5.6.2 Diagnostic Laboratories
8.5.6.3 Other
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Skin Biopsy Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By By Type
8.6.4.1 Shave Biopsy
8.6.4.2 Punch Biopsy
8.6.4.3 Excisional Biopsy
8.6.5 Historic and Forecasted Market Size By By Indication
8.6.5.1 Skin cancer
8.6.5.2 Actinic keratosis
8.6.5.3 Dermatitis
8.6.5.4 Others
8.6.6 Historic and Forecasted Market Size By By End User
8.6.6.1 Hospital and Clinics
8.6.6.2 Diagnostic Laboratories
8.6.6.3 Other
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Skin Biopsy Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By By Type
8.7.4.1 Shave Biopsy
8.7.4.2 Punch Biopsy
8.7.4.3 Excisional Biopsy
8.7.5 Historic and Forecasted Market Size By By Indication
8.7.5.1 Skin cancer
8.7.5.2 Actinic keratosis
8.7.5.3 Dermatitis
8.7.5.4 Others
8.7.6 Historic and Forecasted Market Size By By End User
8.7.6.1 Hospital and Clinics
8.7.6.2 Diagnostic Laboratories
8.7.6.3 Other
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Skin Biopsy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 113.8 Million |
|
Forecast Period 2024-32 CAGR: |
6.1% |
Market Size in 2032: |
USD 193.9 Million |
|
Segments Covered: |
By Type |
|
|
|
By Indication |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Frequently Asked Questions :
The forecast period in the Skin Biopsy Market research report is 2024-2032.
3Derm Systems Inc. (United States), AccuTec Blades Inc. (United States), BD (Becton, Dickinson, and Company) (United States), bioMérieux SA (France), Boston Scientific Corporation (United States), Cardinal Health (United States), Carl Zeiss AG (Germany), DermTech Inc. (United States), Eurofins Scientific (Luxembourg), Hologic Inc. (United States), Leica Microsystems (Germany), Medtronic plc (Ireland), Quest Diagnostics (United States), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (United States), and Other Active Players.
The Skin Biopsy Market is segmented into Type, Indication, End User and region. By Type, the market is categorized into Shave Biopsy, Punch Biopsy, Excisional Biopsy. By Indication, the market is categorized into Skin cancer, Actinic keratosis, Dermatitis, Others. By End User, the market is categorized into Hospital and Clinics, Diagnostic Laboratories, Other. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
The skin biopsy system is one that entails the identification and assessment of skin associated ailments and disorders by taking biopsies on secrete matter from the skin. This market covers various dermatological diseases such as skin cancer, inflammation diseases and infections with diagnosis being critical for patient treatment. Skin biopsies are important in diagnosing the type and character of skin lesions and establishing a differential diagnosis between benign and malignant tumours as well as to design individual treatment protocols. On grounds of diagnostic technologies, global skin biopsy market is experiencing steady growth primarily due to the rising instances of skins disorders, enhanced awareness among the patients as well as the doctors. Furthermore, the growth of factors such as rising healthcare costs and advancement in minimally invasive biopsy procedures also fuelling the market growth.
Skin Biopsy Market Size Was Valued at USD 113.8 Million in 2023, and is Projected to Reach USD 193.9 Million by 2032, Growing at a CAGR of 6.1% From 2024-2032.
